Together, these data demonstrate that the sensitivity of BRAF-mutant melanoma cells to SP2509 and JIB-04 can be predicted based on their differentiation state (Ngfr versus Axl) and the relative levels of Znf217 and Kdm4b proteins. The gene discussed is KDM4B; the disease is melanoma.